Lim, Hyejin <br/><br/>
A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes.  [electronic resource] 

 -  Nature communications  04 2018 
 - 1438 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-018-03939-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autophagy--drug effects<br/>Diabetes Mellitus--drug therapy<br/>HeLa Cells<br/>Humans<br/>Hypoglycemic Agents--chemistry<br/>Lipid Metabolism--drug effects<br/>Male<br/>Metabolic Syndrome--drug therapy<br/>Metabolome--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Obese<br/>Obesity--drug therapy<br/>Oxazoles--chemistry<br/>Stress, Physiological--drug effects